Ocuphire Pharma Inc. (OCUP)
NASDAQ: OCUP
· Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM
Ocuphire Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.09 | -1.01 | -0.19 | -1.14 | -1.32 | -1.92 | -3.61 | 3.23 | -4.58 | -3.6 | 0.54 | -2.27 | -1.9 | -2.29 | -2.62 | -5.15 | -2.52 | -0.41 |
PEG Ratio | 0.04 | 0.01 | -0.00 | 0.34 | -0.38 | -0.05 | 0.02 | -0.02 | 0.60 | 0.03 | -0.00 | 0.19 | 0.07 | 0.82 | -0.06 | 0.10 | 0.03 | 0.09 |
PS Ratio | n/a | n/a | -5.8 | 8.86 | 36.93 | 31.96 | 40.93 | 6.02 | 24.76 | 44.90 | 1.84 | n/a | n/a | n/a | -112.28 | 178.25 | 718.53 | n/a |
PB Ratio | 3.55 | 6.55 | 3.89 | 1.00 | 1.01 | 1.19 | 1.39 | 1.43 | 2.41 | 1.90 | 1.59 | 3.47 | 2.57 | 3.54 | 2.98 | 4.24 | 3.19 | 6.47 |
P/FCF Ratio | -6.05 | -3.69 | -1.53 | -6.68 | -5.63 | -9.57 | 15.22 | -23.92 | 91.98 | -21.54 | 2.55 | -9.16 | -9.83 | -9.92 | -11.51 | -24.32 | -16.6 | -10.92 |
P/OCF Ratio | -6.05 | -3.69 | -1.53 | -6.68 | -5.63 | -9.57 | 15.22 | -23.92 | 91.98 | -21.54 | 2.55 | -9.16 | -9.83 | -9.92 | -11.71 | -24.32 | -16.6 | -10.92 |
OCF/S Ratio | n/a | n/a | 3.79 | -1.33 | -6.56 | -3.34 | 2.69 | -0.25 | 0.27 | -2.08 | 0.72 | n/a | n/a | n/a | 9.59 | -7.33 | -43.28 | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | 0.02 | n/a | n/a | n/a |
Quick Ratio | 1.90 | 1.98 | 3.24 | 6.63 | 10.68 | 8.96 | 13.35 | 13.75 | 7.42 | 10.93 | 17.79 | 5.41 | 5.41 | 6.37 | 6.76 | 8.79 | 9.02 | 5.24 |
Current Ratio | 1.90 | 1.98 | 3.24 | 6.63 | 10.68 | 8.96 | 13.35 | 13.86 | 7.54 | 10.93 | 17.79 | 5.41 | 5.41 | 6.37 | 6.76 | 8.79 | 9.35 | 5.24 |
Asset Turnover | n/a | n/a | -0.12 | 0.10 | 0.02 | 0.03 | 0.03 | 0.22 | 0.08 | 0.04 | 0.81 | n/a | n/a | n/a | -0.02 | 0.02 | 0.00 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.8K | n/a | -1.23K | -1.3K | -3.08K | n/a | n/a | n/a |
Return on Equity | -0.42 | -1.62 | -5.23 | -0.22 | -0.19 | -0.15 | -0.1 | 0.11 | -0.13 | -0.13 | 0.73 | -0.38 | -0.34 | -0.39 | -0.28 | -0.21 | -0.32 | -3.97 |
Return on Assets | -0.19 | -0.17 | -0.95 | -0.19 | -0.17 | -0.14 | -0.09 | 0.10 | -0.11 | -0.12 | 0.69 | -0.31 | -0.28 | -0.33 | -0.24 | -0.18 | -0.28 | -3.22 |
Return on Invested Capital | -0.48 | -0.42 | -1.49 | -0.23 | -0.2 | -0.17 | -0.11 | 0.13 | -0.14 | -0.14 | 0.73 | -0.38 | -0.34 | -0.38 | -0.27 | -0.21 | -0.32 | -0.53 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 6.09 | 0.44 | 0.75 | -1.78 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | n/a | n/a | n/a | 1.00 | 1.00 | -37.29 | n/a |
Net Profit Margin | n/a | n/a | 7.78 | -1.95 | -6.98 | -4.15 | -2.84 | 0.47 | -1.35 | -3.12 | 0.85 | n/a | n/a | n/a | 10.72 | -8.65 | -71.36 | n/a |
Pretax Profit Margin | n/a | n/a | 7.78 | -1.95 | -6.98 | -4.15 | -2.84 | 0.47 | -1.35 | -3.31 | 0.86 | n/a | n/a | n/a | 10.72 | -8.65 | -71.36 | n/a |
Operating Profit Margin | n/a | n/a | 8.42 | -2.07 | -7.49 | -4.5 | -3.21 | 0.54 | -1.47 | -3.51 | 0.86 | n/a | n/a | n/a | 10.44 | -8.65 | -71.37 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | 8.39 | -1.95 | -7.49 | -4.5 | -2.84 | 0.54 | -1.47 | -3.5 | 0.86 | n/a | n/a | n/a | 10.71 | -8.65 | -71.35 | n/a |